2026 Q3 Portfolio Activity
In 2026 Q3, Avidity Partners Management LP maintained a portfolio of 46 distinct positions. They heavily accumulated shares in JADE BIOSCIENCES INC, increasing the position by 17.6%. The fund also reduced its exposure to CG ONCOLOGY INC by 39.2%.
Position History
hover any row below to update
Loading…
Total Positions
46
Quarter
2026 Q3
Top Holding
DNTH (34.3%)
Top 10 Concentration
97.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-46 of 46
Avidity Partners Management LP Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 34.26% | 32.85% |
#1
Prev: #1
|
6.5 |
—
|
-204,591 | -9.7% |
P
S
|
1,899,593 | $167,259,164 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 19.59% | 15.92% |
#2
Prev: #2
|
6.0 |
—
|
-50,000 | -3.6% |
P
S
|
1,348,948 | $95,626,924 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 13.40% | 11.59% |
#3
Prev: #3
|
5.5 |
—
|
25,000 | 3.3% |
P
S
|
785,424 | $65,417,965 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CGON
CALL
CG ONCOLOGY INC
|
CALL Option | 12.34% | — |
#4
Prev: #—
|
8.0 |
—
|
850,000 | — |
NEW
|
850,000 | $60,256,500 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 5.76% | 6.05% |
#5
1
Prev: #4
|
4.8 |
—
|
299,292 | 17.6% |
P
S
|
2,000,000 | $28,100,000 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 5.16% | 4.47% |
#6
1
Prev: #5
|
3.1 |
—
|
no change | no change |
P
S
|
550,000 | $25,212,000 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CATX
PERSPECTIVE THE...
|
Healthcare | 3.42% | 3.44% |
#7
1
Prev: #6
|
1.9 |
—
|
-232,000 | -3.7% |
P
S
|
6,067,999 | $16,686,997 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AKTS
AKTIS ONCOLOGY ...
|
Healthcare | 1.93% | 2.50% |
#8
1
Prev: #7
|
1.8 |
—
|
no change | no change |
P
S
|
484,200 | $9,427,374 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IMUX
IMMUNIC INC
|
Healthcare | 1.28% | 1.65% |
#9
2
Prev: #11
|
1.5 |
—
|
no change | no change |
P
S
|
669,941 | $6,230,451 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MOBI
MOBIA MED INC
|
Healthcare | 0.63% | 1.71% |
#10
1
Prev: #9
|
0.3 |
—
|
-473,606 | -59.3% |
P
S
|
324,676 | $3,068,188 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 0.57% | 1.71% |
#11
3
Prev: #8
|
0.2 |
—
|
-50,000 | -71.4% |
P
S
|
20,000 | $2,758,600 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NVCT
NUVECTIS PHARMA...
|
Healthcare | 0.43% | 0.59% |
#12
10
Prev: #22
|
0.2 |
—
|
-99,585 | -49.8% |
P
S
|
100,415 | $2,120,765 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MSLE
SATELLOS BIOSCI...
|
Healthcare | 0.29% | 0.48% |
#13
12
Prev: #25
|
0.1 |
—
|
-223,750 | -57.7% |
P
S
|
164,019 | $1,394,162 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 0.25% | 0.44% |
#14
13
Prev: #27
|
0.6 |
—
|
-938,013 | -18.8% |
P
S
|
4,060,254 | $1,219,700 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KPTI
KARYOPHARM THER...
|
Healthcare | 0.22% | 1.45% |
#15
2
Prev: #13
|
0.6 |
—
|
-39,587 | -4.3% |
P
S
|
884,900 | $1,079,578 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SENS
SENSEONICS HLDG...
|
Healthcare | 0.21% | 1.46% |
#16
4
Prev: #12
|
0.1 |
—
|
-1,500,000 | -93.8% |
P
S
|
100,000 | $1,017,000 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SCYX
SCYNEXIS INC
|
Healthcare | 0.16% | 0.17% |
#17
20
Prev: #37
|
0.1 |
—
|
-106,593 | -41.0% |
P
S
|
153,613 | $758,848 | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AVLN
AVALYN PHARMACE...
|
Healthcare | 0.12% | 0.32% |
#18
13
Prev: #31
|
0.0 |
—
|
-40,000 | -66.7% |
P
S
|
20,000 | $569,800 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TRVI
TREVI THERAPEUT...
|
Healthcare | 0.00% | 0.02% |
Sold All 😨
(Was: #45) |
0.0 |
—
|
-6,660 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SVRA
SAVARA INC
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #44) |
0.0 |
—
|
-50,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BBOT
BRIDGEBIO ONCOL...
|
Healthcare | 0.00% | 0.05% |
Sold All 😨
(Was: #43) |
0.0 |
—
|
-43,853 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
LEGN
LEGEND BIOTECH ...
|
Healthcare | 0.00% | 0.07% |
Sold All 😨
(Was: #42) |
0.0 |
—
|
-15,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PTON
PELOTON INTERAC...
|
Consumer Cyclical | 0.00% | 0.09% |
Sold All 😨
(Was: #41) |
0.0 |
—
|
-100,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.00% | 0.12% |
Sold All 😨
(Was: #40) |
0.0 |
—
|
-10,000 | -100.0% |
CLOSED
|
— | $— | 2021 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABT
ABBOTT LABORATO...
|
Healthcare | 0.00% | 0.15% |
Sold All 😨
(Was: #39) |
0.0 |
—
|
-10,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 0.00% | 0.16% |
Sold All 😨
(Was: #38) |
0.0 |
—
|
-75,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ODD
ODDITY TECH LTD
|
Consumer Defensive | 0.00% | 0.17% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-70,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 0.00% | 0.19% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-80,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NTLA
INTELLIA THERAP...
|
Healthcare | 0.00% | 0.20% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-75,000 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GMAB
GENMAB A/S
|
Healthcare | 0.00% | 0.22% |
Sold All 😨
(Was: #33) |
0.0 |
—
|
-50,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KLRA
KAILERA THERAPE...
|
Healthcare | 0.00% | 0.28% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-80,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PHAT
PHATHOM PHARMAC...
|
Healthcare | 0.00% | 0.35% |
Sold All 😨
(Was: #30) |
0.0 |
—
|
-200,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRL
CHARLES RIV LAB...
|
Healthcare | 0.00% | 0.36% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-10,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 0.00% | 0.40% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-20,000 | -100.0% |
CLOSED
|
— | $— | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ALMR
ALAMAR BIOSCIEN...
|
Healthcare | 0.00% | 0.48% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-110,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-80,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PODD
INSULET CORP
|
Healthcare | 0.00% | 0.59% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-24,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 0.00% | 0.62% |
Sold All 😨
(Was: #21) |
0.0 |
—
|
-265,934 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
EHC
ENCOMPASS HEALT...
|
Healthcare | 0.00% | 0.68% |
Sold All 😨
(Was: #20) |
0.0 |
—
|
-42,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GPCR
STRUCTURE THERA...
|
Healthcare | 0.00% | 0.84% |
Sold All 😨
(Was: #19) |
0.0 |
—
|
-98,000 | -100.0% |
CLOSED
|
— | $— | 2023 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VIR
VIR BIOTECHNOLO...
|
Healthcare | 0.00% | 0.85% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-519,300 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 0.00% | 0.88% |
Sold All 😨
(Was: #17) |
0.0 |
—
|
-70,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TEM
TEMPUS AI INC
|
Healthcare | 0.00% | 0.97% |
Sold All 😨
(Was: #16) |
0.0 |
—
|
-105,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.00% | 1.08% |
Sold All 😨
(Was: #15) |
0.0 |
—
|
-100,000 | -100.0% |
CLOSED
|
— | $— | 2022 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TEVA
TEVA PHARMACEUT...
|
Healthcare | 0.00% | 1.09% |
Sold All 😨
(Was: #14) |
0.0 |
—
|
-200,000 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 0.00% | 1.70% |
Sold All 😨
(Was: #10) |
0.0 |
—
|
-77,800 | -100.0% |
CLOSED
|
— | $— | 2019 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-46 of 46 holdings